Allergan vs. Sandoz – CAFC Strikes Down Allergan’s Latisse Patent Claim 30

Allergan vs. Sandoz

In the case of Allergan vs. Sandoz, the United States Court of Appeals for the Federal Circuit (CAFC) has invalidated a key Allergan patent covering the use of prostaglandin F (PGF) analogs for hair growth, handing a significant win to generic manufacturer Sandoz Inc.

Merck Serono S.A. v. Hopewell Pharma Ventures, Inc.

Merck Serono S.A. v. Hopewell Pharma Ventures Inc

In the case Merck Serono S.A. v. Hopewell Pharma Ventures, Inc., the Federal Circuit upheld a Patent Trial and Appeal Board decision invalidating claims related to Merck’s multiple sclerosis drug Mavenclad, an oral formulation of the compound Cladribine. Merck Serono S.A. v. Hopewell Pharma Ventures, Inc. – Basic Details: Merck Serono S.A. v. Hopewell Pharma … Read more

We would love to hear from you! Get in touch with us for any queries, feedback, or collaboration opportunities.